Explore

Trump Administration Ends $9.8 Billion Medicare Subsidy, Potentially Increasing Part D Premiums for Beneficiaries

Trump Administration Ends $9.8 Billion Medicare Subsidy, Potentially Increasing Part D Premiums for Beneficiaries

The Trump administration has announced the termination of the Part D Premium Stabilization Demonstration, a $9.8 billion Medicare subsidy introduced under the Inflation Reduction Act of 2022. This subsidy was designed to prevent insurance companies from raising premiums on Part D drug plans after the Act capped beneficiaries' out-of-pocket prescription costs at $2,000 annually, starting in 2025. The Kaiser Family Foundation (KFF) reported that the demonstration successfully stabilized premiums, keeping the average monthly Part D premium under $40 in 2025. The U.S. Government Accountability Office (GAO) estimated that without the program, monthly premiums would have jumped from approximately $43 in 2024 to $81 in 2025. The Centers for Medicare and Medicaid Services (CMS) confirmed the end of the program on July 28, 2026.

JAMA Piece Argues Against Mandatory Human Oversight in AI Diagnostics as AI Outperforms Doctors

JAMA Piece Argues Against Mandatory Human Oversight in AI Diagnostics as AI Outperforms Doctors

An opinion piece published in the medical journal JAMA advocates for regulators to avoid mandating human oversight in AI-driven diagnostics, asserting that artificial intelligence is rapidly surpassing human capabilities in medical reasoning. The authors, including bioethicist Ezekiel Emanuel and Curai Health CEO Neal Khosla, contend that once AI systems become demonstrably superior to human doctors, requiring a human 'in the loop' could introduce errors rather than prevent them. They cite a meta-analysis of 106 experiments and a study using real patient cases where GPT-4 alone achieved a 92% accuracy in diagnostic reasoning, while doctors using the same model scored only 76%. This perspective challenges the stance of physician groups like the American Medical Association, which maintain that AI should support, not replace, doctors. The authors predict that by 2030, autonomous AI will be ready for many cognitive medical tasks, necessitating a reevaluation of liability, payment structures, regulation, and m...

Four States Offer Enhanced Medigap Protections Beyond Federal Standards

Four States Offer Enhanced Medigap Protections Beyond Federal Standards

Federal law provides a six-month protected enrollment period for Medigap policies when individuals turn 65 and enroll in Medicare Part B, during which insurers cannot deny coverage or charge more due to health conditions. However, outside this window, most states allow insurers to medically underwrite policies, potentially denying coverage or increasing costs for individuals with pre-existing conditions like diabetes. Only four states—Connecticut, New York, Massachusetts, and Maine—offer significant Medigap protections that extend beyond this federal window. Connecticut and New York provide continuous guaranteed access to Medigap. Massachusetts offers broad protections throughout the year, while Maine mandates insurers to offer at least Plan A during an annual guaranteed-issue period. Other states may offer narrower opportunities, such as 'birthday windows' for existing Medigap policyholders, but these generally do not provide unrestricted access for all Medicare Advantage members seeking to switch to a su...

Medical Field Shifts from 'Personalized' to 'Precision' Medicine, Emphasizing Data-Driven Treatment

Medical Field Shifts from 'Personalized' to 'Precision' Medicine, Emphasizing Data-Driven Treatment

The medical field is undergoing a significant linguistic and conceptual shift, moving from the term 'personalized medicine' to 'precision medicine.' According to Matt Might, Ph.D., director of the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham, this change reflects a deeper evolution in how healthcare is approached. While 'personalized' might suggest custom-built treatments for individuals, 'precision medicine' focuses on using extensive patient data—including genetics, lab results, medical history, and biological details—to identify groups of patients who are likely to respond well to specific treatments. This data-driven approach allows doctors to make more informed decisions, moving away from a one-size-fits-all model. The Hugh Kaul Personalized Medicine Institute itself rebranded to the Precision Medicine Institute, signaling this broader trend. The American Medical Association also views 'personalized' as potentially misleading, advocating for 'precision' to accurate...

Americans for Tax Reform Urges CMS to Withdraw Medicare Drug Price Control Program Rule

Americans for Tax Reform Urges CMS to Withdraw Medicare Drug Price Control Program Rule

Americans for Tax Reform (ATR) has formally opposed the Centers for Medicare & Medicaid Services’ (CMS) proposed rule concerning the Medicare Drug Price Negotiation Program (DPNP) and Medicare Prescription Drug Benefit Program (CMS-4215-P). ATR is urging CMS to withdraw the rule entirely or, at minimum, significantly narrow the authority it claims. The organization argues that codifying this program into permanent regulation legitimizes a 'price control scheme' that is merely a 'negotiation' in name. ATR contends that the program, authorized by the Inflation Reduction Act (IRA) and signed by President Biden, allows the HHS Secretary to effectively set drug prices and impose substantial taxes (up to 95% of sales) on companies that charge more. The program is slated to cover 10 drugs in 2026, expanding to 60 by 2029, with an additional 20 drugs annually thereafter.

Costco Partners with SCAN Health Plan to Offer Medicare Advantage Plans

Costco Partners with SCAN Health Plan to Offer Medicare Advantage Plans

Costco Partners with SCAN Health Plan to Offer Medicare Advantage Plans

Diabetes Diagnosis Can Restrict Medicare Advantage Enrollees from Switching to Original Medicare in Most States

Diabetes Diagnosis Can Restrict Medicare Advantage Enrollees from Switching to Original Medicare in Most States

In most U.S. states, a diabetes diagnosis can effectively 'lock' individuals into their Medicare Advantage plans, making it difficult to switch to Original Medicare with a Medigap policy. This is due to medical underwriting requirements for Medigap plans outside of specific enrollment windows. While federal law provides a six-month open enrollment period for Medigap when a person first turns 65 and enrolls in Medicare Part B, and a 12-month trial right for new Medicare Advantage enrollees to return to Original Medicare, these protections are time-limited. Once these windows close, insurers in most states can deny Medigap coverage or charge higher premiums based on pre-existing conditions like diabetes, especially if insulin use or complications are present. Only four states—Connecticut, New York, Massachusetts, and Maine—offer significant Medigap protections beyond the federal windows.

Connecticut Implements Penalties for Hospitals Exceeding Healthcare Cost Growth Benchmarks

Connecticut Implements Penalties for Hospitals Exceeding Healthcare Cost Growth Benchmarks

Connecticut lawmakers have approved new measures to penalize hospitals whose annual healthcare spending growth exceeds state-established benchmarks. This initiative aims to curtail rapidly rising healthcare costs, a long-standing concern for state officials. Starting in 2029, hospitals that fail to keep cost growth at or below 3.9% may be required to submit a corrective plan. If these plans are not met, hospitals could face a community health investment penalty of up to $400,000, with the amount varying based on the hospital's size. This policy builds on previous efforts to measure healthcare spending growth, which lacked enforcement mechanisms. Comptroller Sean Scanlon, a key negotiator for the state, emphasized that the goal is to save millions of dollars for residents by keeping healthcare cost growth under 4% annually. The state has also committed over $1.6 billion in additional funding to hospitals over the next five years to help offset potential losses from federal program changes.

Trump picks White House adviser Heidi Overton to run FDA, source says

Trump picks White House adviser Heidi Overton to run FDA, source says

By Yasmeen Abutaleb and Carlos Méndez Aug 18 (Reuters) - U.S. President Donald Trump has chosen White House policy aide Heidi Overton to lead the Food and Drug Administration, a source familiar with the matter said on Tuesday, months after previous chief Marty Makary quit.

New CPT Codes Introduced for Nasal Ablation Procedures to Treat Chronic Rhinitis

New CPT Codes Introduced for Nasal Ablation Procedures to Treat Chronic Rhinitis

The American Medical Association (AMA) has introduced two new Current Procedural Terminology (CPT) codes, 31242 and 31243, effective January 1, 2024, for nasal ablation procedures targeting chronic rhinitis. These codes specifically cover the endoscopic destruction of the posterior nasal nerve (PNN) using either radiofrequency ablation (31242) or cryoablation (31243). Chronic rhinitis is characterized by persistent inflammation or dysfunction of the nasal mucosa, leading to symptoms such as nasal congestion, rhinorrhea, sneezing, and itching for extended periods. While initial treatments often involve intranasal saline, corticosteroids, and oral antihistamines, many patients do not achieve adequate symptomatic relief, making nasal ablation a viable alternative. The choice between 31242 and 31243 depends solely on the method of ablation used by the provider. Both procedures can be performed in either a physician's office or a facility setting. The new codes aim to standardize the reporting of these specific...

Asheville Citizen-Times

Opinion: Time to weigh in on which hospital systems can best serve our community

Opinion: Time to weigh in on which hospital systems can best serve our community

A survey on which of the four hospital systems in WNC can best serve our community.

Medicare Beneficiaries Face Critical One-Time Medigap Enrollment Window

Medicare Beneficiaries Face Critical One-Time Medigap Enrollment Window

Many Medicare beneficiaries are unaware of a crucial, one-time six-month window, known as the Medigap Open Enrollment Period, which significantly impacts their ability to secure supplemental health insurance. This period commences the first month an individual is aged 65 or older and has enrolled in Medicare Part B. During this specific timeframe, federal law mandates that Medigap insurers must sell any policy they offer without the ability to reject an applicant or charge higher premiums based on pre-existing health conditions. While coverage for pre-existing conditions might still be subject to a waiting period, the application itself cannot be denied on medical grounds. Crucially, this protected enrollment window does not recur annually, unlike Medicare's Annual Enrollment Period for Medicare Advantage and Part D prescription drug plans. A common pitfall occurs when individuals initially opt for a Medicare Advantage plan, assuming they can easily switch back to Original Medicare and add Medigap later. H...